Khaled Awad, MD
Clinical Cardiac Electrophysiology · Austin, TXNPI 1326236712
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Biosense Webster, Inc. at 37.5% of the total.
Across 215 payments — averaging $238.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$19K
- Medical Device Business Services, Inc.$13K
- Abbott$11K
- Cvrx, Inc.$4K
- Medtronic$2K
- Biotronik Inc.$921
- plus $993 from 12 others
Across 358 payments — averaging $1938.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cvrx, Inc.$589K
- Biotronik Inc.$69K
- Biosense Webster, Inc.$36K
What the payments were for
- Consulting fees$25,45050%
- Travel & lodging$16,83233%
- Food & beverage$9,01118%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 60 | $19,253 |
| Medical Device Business Services, Inc. | 17 | $12,966 |
| Abbott | 85 | $11,454 |
| Cvrx, Inc. | 4 | $3,570 |
| Medtronic(2 entities) | 23 | $2,136 |
| Biotronik Inc. | 5 | $921 |
| Boston Scientific | 7 | $387 |
| Cardiva Medical, Inc. | 3 | $172 |
| Shockwave Medical, Inc | 1 | $119 |
| Edwards Lifesciences | 1 | $116 |
| Pfizer | 2 | $49 |
| Baxter Healthcare | 1 | $31 |
| Covidien LP | 1 | $23 |
| Smith+Nephew | 1 | $22 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Kestra Medical Technology Services, Inc. | 1 | $17 |
| Vital Connect, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$25,762
- AMPLATZER AMULET$6,937
- Barostim Neo System$3,510
- AVEIR$1,491
- Thermocool SF$842
- Carto 3 System$794
- AURORA EV-ICD MRI SURESCAN$615
- Accent Pacemaker$528
- EVERA MRI XT DR SURESCAN$386
- GALLANT$347
- COBALT DR MRI SURESCAN$334
- Micra$237
- CARDIOMEMS$196
- ASSURITY$186
- Ensite Cardiac Mapping System$182
- Acticor 7 VR-T DX$149
- NUVISION ICE CATHETER$148
- QDOT MICRO Catheter$148
- RHYTHMIA$144
- NA$132
How this compares
$51,293 in reported general payments places this provider in the 65th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 397 | $413,203 |
| XareltoRivaroxaban | 139 | $125,796 |
| Dofetilide | 154 | $32,937 |
| Mexiletine Hcl | 150 | $17,402 |
| MultaqDronedarone Hcl | 13 | $10,409 |
| Metoprolol Succinate | 304 | $2,451 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 86 | $2,321 |
| Verapamil SrVerapamil Hcl | 22 | $1,810 |
| Metoprolol Tartrate | 155 | $1,106 |
| Verapamil ErVerapamil Hcl | 66 | $993 |
| Flecainide Acetate | 28 | $893 |
| Potassium Chloride | 22 | $816 |
| Carvedilol | 82 | $623 |
| Amlodipine Besylate | 102 | $510 |
| ClopidogrelClopidogrel Bisulfate | 66 | $480 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $49 | $413,203397 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Austin
- Andrea NataleAustin$1.3M
- Jason ZagrodzkyAustin$961K
- Amin Al-AhmadAustin$771K
- Rodney HortonAustin$553K
- Robert CanbyAustin$224K
- Weeranun BodeAustin$178K
- David TschoppAustin$114K
- Mauricio HongAustin$79K
- Michael DelaughterBedford$1.6M
- Dale YooMcKinney$585K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.